Pfizer Inc. in Pearl River filed a tax challenge on July 30th in New York Supreme Court, asserting that its assessed value of $62.5 million should be lowered to $4.35 million, a 93 percent reduction
Continue Reading
Taking A Deep Dive With Dr. Phil Dormitzer, Vice President and Chief Scientific Officer for Viral Vaccines at Pfizer
Continue Reading
Taking A Deep Dive With Dr. Phil Dormitzer, Vice President and Chief Scientific Officer for Viral Vaccines at Pfizer
Continue Reading
The U.S.-based company, which is working alongside German drug maker BioNTech, said the first human participants in the U.S have been dosed with the potential vaccine, BNT162.
Continue Reading
Dr. Phil Dormitzer, Vice President and Chief Scientific Officer for Viral Vaccines at Pfizer, Talks With RCBJ About Coronavirus
Continue Reading
Struggling to reinvent the sprawling Pfizer campus in Pearl River, the New York Center for Innovation (IRG) is considering turning Building 100 into studio and one-bedroom apartments.
Continue Reading
A drug company that develops injectable and oral pharmaceuticals is leasing space on the New York Center for Innovation campus in Pearl River.
Continue Reading
